Initial Management of Acute Ischemic Stroke
All patients with acute ischemic stroke should be admitted to a dedicated stroke unit for comprehensive monitoring and immediate initiation of secondary prevention measures, including antiplatelet therapy within 24-48 hours, high-intensity statin therapy regardless of baseline cholesterol, blood pressure management, and evaluation for cardioembolic sources requiring anticoagulation. 1, 2
Immediate Hospital Admission and Monitoring
- Admit all patients to a specialized stroke unit with cardiac and neurologic monitoring for at least the first 24 hours to detect arrhythmias (particularly atrial fibrillation), myocardial ischemia, and neurological deterioration 1, 3
- Patients with large hemispheric infarcts, right hemispheric strokes, or posterior fossa infarctions require particularly close observation for cerebral edema, which typically peaks at 3-5 days post-stroke 1
- Continue cardiac monitoring beyond 24 hours with Holter monitoring or event-loop recording for several days to detect occult atrial fibrillation that may not be apparent at presentation 1
Antiplatelet Therapy Initiation
- Start aspirin 160-325 mg within 24-48 hours after stroke onset for patients not receiving thrombolytic therapy 2, 3
- For minor stroke or high-risk TIA, initiate dual antiplatelet therapy (aspirin 160-325 mg loading dose plus clopidogrel 300-600 mg loading dose, followed by aspirin 81 mg plus clopidogrel 75 mg daily) within 12-24 hours and continue for exactly 21 days, then switch to monotherapy 4
- After 21 days of dual therapy, transition to clopidogrel 75 mg daily as the preferred long-term antiplatelet agent 2, 4
High-Intensity Statin Therapy
- Initiate atorvastatin 80 mg daily immediately for all ischemic stroke patients, regardless of baseline cholesterol levels 2
- Target LDL-C <70 mg/dL (<1.8 mmol/L) or achieve ≥50% reduction from baseline for patients with atherosclerotic disease 2, 4
- Check lipid panel 4-12 weeks after statin initiation or dose adjustment, then every 3-12 months 2
Blood Pressure Management
- Allow permissive hypertension initially (do not aggressively lower BP in the hyperacute phase unless >220/120 mmHg or patient is receiving thrombolysis) 3
- Begin antihypertensive therapy within 24 hours after the acute phase with target BP <130/80 mmHg for most patients, or <120/80 mmHg for optimal secondary prevention 2, 5, 4
- Preferred agents include thiazide diuretics, ACE inhibitors (particularly perindopril), or angiotensin II receptor blockers (ARBs) 2, 6
Urgent Etiologic Evaluation
Vascular Imaging (perform within 24 hours)
- CT angiography, MR angiography, or carotid ultrasound to identify ipsilateral carotid stenosis requiring urgent intervention 4
- For symptomatic carotid stenosis 70-99% (NASCET criteria), perform carotid endarterectomy urgently, ideally within the first few days and no later than 2 weeks post-stroke 4
Cardiac Evaluation
- Transthoracic echocardiography to examine for cardioembolic sources including left ventricular thrombus, valvular disease, and reduced ejection fraction 1, 4
- Transesophageal echocardiography is reasonable when identification of left atrial thrombus, patent foramen ovale, or aortic arch atherosclerosis will alter management 1
- Extended cardiac monitoring (minimum 24 hours, consider up to 30 days with event monitors) to detect paroxysmal atrial fibrillation 1
Anticoagulation for Cardioembolic Stroke
- For atrial fibrillation identified as stroke mechanism, initiate oral anticoagulation with direct oral anticoagulants (DOACs) preferred over warfarin 2, 4
- DOAC options include dabigatran, apixaban, edoxaban, or rivaroxaban 4
- If using warfarin, target INR 2.0-3.0 2
- Timing of anticoagulation initiation depends on infarct size: small infarcts can begin anticoagulation at 3-4 days, moderate infarcts at 7-10 days, and large infarcts should wait 2 weeks to minimize hemorrhagic transformation risk 7
Prevention of Acute Complications
Deep Vein Thrombosis Prophylaxis
- Subcutaneous anticoagulants (unfractionated heparin 5000 IU twice daily or low-molecular-weight heparin such as enoxaparin 40 mg once daily) for immobilized patients 1
- For patients with contraindications to anticoagulation, use intermittent external compression devices or aspirin 1
Aspiration Prevention and Nutrition
- Perform bedside swallowing assessment (water swallow test) before allowing any oral intake 1, 3
- High NIHSS score, wet voice after swallowing, incomplete oral-labial closure, or cranial nerve palsies indicate high aspiration risk 1
- If swallowing is impaired, insert nasogastric or nasoduodenal tube for feeding; consider percutaneous endoscopic gastrostomy (PEG) if prolonged need is anticipated 1
Infection Prevention
- Monitor for pneumonia (most common cause of post-stroke death) and urinary tract infections 1
- Avoid indwelling bladder catheters when possible; use intermittent catheterization or acidification of urine to reduce infection risk 1
- Treat infections promptly with appropriate antibiotics 1
Glycemic Control
- Target HbA1c ≤7.0% for most diabetic patients 4
- Avoid hypoglycemia and extreme hyperglycemia in the acute phase 1
Lifestyle Modifications (Initiate During Hospitalization)
- Complete smoking cessation is non-negotiable: provide counseling and pharmacotherapy (nicotine replacement, bupropion, or varenicline) 2, 5
- Mediterranean-style diet: emphasize plant-based foods, healthy fats, reduce saturated fat to <7% of total calories, and limit sodium to <2000 mg daily 2, 5, 4
- Physical activity: prescribe at least 30 minutes of moderate-intensity aerobic exercise daily (or 10 minutes of low/moderate-intensity activity 4 days/week, or 20 minutes of vigorous activity twice weekly) 2, 5
Rehabilitation and Discharge Planning
- Initiate physical therapy, occupational therapy, and speech therapy during hospitalization 1, 5, 3
- Assess for post-stroke depression and provide treatment if indicated 1
- Provide comprehensive discharge planning with written action plans detailing medications, follow-up appointments, warning signs of recurrent stroke, and lifestyle modifications 1, 2, 5
- Schedule early follow-up with neurologist (within 2 weeks), internist, and primary care physician 1, 2
Common Pitfalls to Avoid
- Do not prolong dual antiplatelet therapy beyond 21-30 days unless there is a specific coronary indication, as bleeding risk increases without additional benefit 4
- Do not combine aspirin plus clopidogrel long-term for cerebrovascular prevention in patients without acute coronary disease 4
- Do not use anticoagulation routinely for presumed arterial (non-cardioembolic) stroke 4
- Do not initiate anticoagulation in TIA/stroke without first excluding intracranial hemorrhage with CT or MRI 4
- Do not delay carotid endarterectomy for symptomatic high-grade stenosis; benefit is greatest when performed within days of the index event 4
Quality Monitoring
- Implement hospital-based or outpatient quality monitoring programs to track adherence to secondary prevention guidelines, including antiplatelet/anticoagulation use, statin therapy, blood pressure control, and smoking cessation counseling 2, 5
- Approximately 12% of stroke patients are readmitted within 30 days; nurse-led transitional stroke clinics with follow-up phone calls can reduce readmission rates 1